FGF21 and metabolic dysfunction-associated steatotic liver disease: Although the role of miR-149 in the liver remains unclear, it is elevated in a HFD-induced NAFLD mouse model and fibroblast growth factor-21 (FGF-21) was identified as its target (Xiao et al., 2016; Chen et al., 2020).